Fertility and infertility in rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 26, Issue 3, 2014, Pages 308-314

  Provost, Meredith ^a   Eaton, Jennifer L ^a   Clowse, Megan E B ^b  

^a Division of Reproductive Endocrinology and Fertility   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

fertility; infertility; pregnancy; rheumatoid arthritis

Indexed keywords

METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT;

COHORT ANALYSIS; CONCEPTION; FAMILY SIZE; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; INFLAMMATION; MATERNAL AGE; OVARIAN RESERVE; OVARY FUNCTION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; UNITED STATES; AGING; ARTHRITIS, RHEUMATOID; COMPLICATION; DECISION MAKING; FEMALE; FERTILITY; INFERTILITY, FEMALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PSYCHOLOGY; SEXUAL BEHAVIOR;

AGING; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHOICE BEHAVIOR; FEMALE; FERTILITY; HUMANS; INFERTILITY, FEMALE; PREGNANCY; SEXUAL BEHAVIOR;

EID: 84897559015     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000058     Document Type: Review

References (78)

1. Forger F, Vallbracht I, Helmke K, et al. Pregnancy mediated improvement of rheumatoid arthritis. Swiss Med Wkly 2012; 142:w13644.
2. Østensen M, Villiger PM, Förger F. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 2012; 11:A437-A446.
3. Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 2007; 29:185-191.
4. Del Junco DJ, Annegers JF, Coulam CB, Luthra HS. The relationship between rheumatoid arthritis and reproductive function. Br J Rheumatol 1989; 28 (Suppl 1):33; discussion 42-45.
5. Tsepelidis S, Devreker F, Demeestere I, et al. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normoovulatory women. Hum Reprod 2007; 22:1837-1840.
6. Hargreaves ER. A survey of rheumatoid arthritis in West Cornwall; a report to the Empire Rheumatism Council. Ann Rheum Dis 1958; 17:61-75.
7. Kay A, Bach F. Subfertility before and after the development of rheumatoid arthritis in women. Ann Rheum Dis 1965; 24:169-173.
8. Hazes JMW, Dijkmans BAC, Vandenbroucke JP, et al. Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum 1990; 33:1770-1775.
9. Spector TD, Da Silva JA. Pregnancy and rheumatoid arthritis: an overview. Am J Reprod Immunol (New York, N Y 1989) 1992; 28:222-225.
10. Katz PP. Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Rheum 2006; 55:217-223.
11. Nelson JLEE, Koepsell TD, Dugowson CE, et al. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum 1993; 36:7-14.
12. Flaisler F, Hedon B, Sany J, Combe B. A study of ovarian function in rheumatoid arthritis. Rev Rhum Engl Ed 1995; 62:549-554.
13. Steen VD, Medsger TA Jr. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum 1999; 42:763-768.
14. Pope JE, Bellamy N, Stevens A. The lack of associations between rheumatoid arthritis and both nulliparity and infertility. Semin Arthritis Rheum 1999; 28:342-350.
15. Jawaheer D, Zhu JL, Nohr EA, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011; 63:1517-1521.
16. Skomsvoll JF, Ostensen M, Baste V, Irgens LM. Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women. J Rheumatol 2001; 28: 2310-2314.
17. Wallenius M, Skomsvoll JF, Irgens LM, et al. Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford) 2011; 50:1162-1167.
18. American College of Obstetricians, Gynecologists. Age-related fertility decline. ACOG Committee opinion No. 413. Obstet Gynecol 2008; 112: 409-411.
19. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000; 21:200-214.
20. Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992; 7:1342-1346.
21. Menken J, Trussell J, Larsen U. Age and infertility. Science 1986; 233:1389-1394.
22. Golding A, Haque UJ, Giles JT. Rheumatoid arthritis and reproduction. Rheum Dis Clin North Am 2007; 33:319-343; vi-vii.
23. Byrne J, Mulvihill J. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 1987; 317:1315-1321.
24. The Committee on Gynecologic Practice of the American College of Obstetricians, Gynecologists, Medicine, The Practice Committee of the American Society for Reproductive. Age-related fertility decline: a committee opinion. Fertil Steril 2008; 90:S154-S155.
25. Kevenaar ME, Meerasahib MF, Kramer P, et al. Serum antimullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006; 147:3228-3234.
26. Dorgan JF, Spittle CS, Egleston BL, et al. Assay reproducibility and withinperson variation of Mü llerian inhibiting substance. Fertil Steril 2010; 94:301-304.
27. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21:3103-3107.
28. Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. Lippincott Williams & Wilkins; 2012.
29. Brouwer J, Laven JSE, Hazes JMW, et al. Levels of serum anti-Mü llerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013; 65:1534-1538.
30. Ostensen M. Counselling women with rheumatic disease: how many children are desirable? Scand J Rheumatol 1991; 20:121-126.
31. Clowse ME, Chakravarty E, Costenbader KH, et al. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012; 64:668-674.
32. Helland Y, Kjeken I, Steen E, et al. Rheumatic diseases and sexuality: disease impact and self-management strategies. Arthritis Care Res (Hoboken) 2011; 63:743-750.
33. Hill J. Effects of rheumatoid arthritis on sexual activity and relationships. Rheumatology 2003; 42:280-286.
34. Helland Y, Dagfinrud H, Kvien TK. Perceived influence of health status on sexual activity in RA patients: associations with demographic and diseaserelated variables. Scand J Rheumatol 2009; 37:194-199.
35. Josefsson KA, Gard G. Women's experiences of sexual health when living with rheumatoid arthritis: an explorative qualitative study. BMC Musculoskelet Disord 2010; 11:240.
36. Esselens G, Enzlin P. Sexual dysfunction in patients with rheumatoid arthritis: a controlled study. Ann Rheum Dis 2004; 63:184.
37. Kraaimaat FW, Bakker AH, Janssen E, Bijlsma JWJ. Intrusiveness of rheumatoid arthritis on sexuality in male and female patients living with a spouse. Arthritis Care Res (Hoboken) 1996; 9:120-125.
38. Østensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol 2004; 18:219-232.
39. Jabbour HN, Sales KJ. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 2004; 15:398-404.
40. Rashid NA, Lalitkumar S, Lalitkumar PG, Gemzell-Danielsson K. Endometrial receptivity and human embryo implantation. Am J Reprod Immunol 2011; 66 (Suppl 1):23-30.
41. Gemzell-Danielsson K, HambergM. Endocrinology: the effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2a concentrations. Hum Reprod 1994; 9:1626-1630.
42. King AE, Critchley HOD. Oestrogen and progesterone regulation of inflammatory processes in the human endometrium. J Steroid Biochem Mol Biol 2010; 120:116-126.
43. Yusoff Dawood M. Nonsteroidal antiinflammatory drugs and reproduction. Am J Obstet Gynecol 1993; 169:1255-1265.
44. Eppig J. Prostaglandin E2 stimulates cumulus expansion and hyaluronic acid synthesis by cumuli oophori isolated from mice. Biol Reprod 1981; 25:191-195.
45. Hizaki H, Segi E, Sugimoto Y, et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci USA 1999; 96:10501-10506.
46. Reich R, Daphna-Iken D, Chun SY, et al. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: role of eicosanoids. Endocrinology 1991; 129:1869-1875.
47. Markosyan N, Duffy DM. Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology 2009; 150:435-444.
48. Hester KE, Harper MJK, Duffy DM. Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in nonhuman primates when administered to simulate emergency contraception. Hum Reprod 2010; 25:360-367.
49. Duffy D, Stouffer R. Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Hum Reprod 2002; 17:2825-2831.
50. Duffy D, Stouffer R. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle. Mol Hum Reprod 2001; 7:731-739.
51. McCann NC, Lynch TJ, Kim SO, Duffy DM. The COX-2 inhibitor meloxicam prevents pregnancy when administered as an emergency contraceptive to nonhuman primates. Contraception 2013; 88:744-748.
52. Yoshinaga K. Uterine receptivity for blastocyst implantation. Ann N Y Acad Sci 1988; 541:424-431.
53. Psychoyos A. Uterine receptivity for nidationa. Ann N Y Acad Sci 1986; 476:36-42.
54. Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005; 11:613-630.
55. Maybin J, Critchley HOD, Jabbour HN. Inflammatory pathways in endometrial disorders. Molecular and Cellular Endocrinology 2011; 335:42-51.
56. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic diseasemodifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59:762-784.
57. Østensen ME, Skomsvoll JF. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 2004; 5:571-580.
58. Bloor M, Paech M. Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation. Anesth Analg 2013; 116:1063-1075.
59. Brooks M. Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 9343:9-13.
60. Office of the Commissioner. For Women-Medicine and Pregnancy [Internet]. [date unknown], [no volume].
61. Ostensen M. Nonsteroidal anti-inflammatory drugs during pregnancy. Scand J Rheumatol Suppl 1998; 107:128-132.
62. Akil M, Amos RS, Stewartf P, Sheffield S. Infertility may sometimes be associated with NSAID consumption. Rheumatology (Oxford) 1996; 35:76-78.
63. Smith G, Roberts R, Hall C, Nuki G. Rerversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1996; 35:458-462.
64. Weiden R, Van der. Wouters J. Infertility may sometimes be associated with nonsteroidal anti-inflammatory drug consumption. Rheumatology 1997; 36:605-1605.
65. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000; 160:610-619.
66. Mendonça LL, Khamashta MA, Nelson-Piercy C, et al. Nonsteroidal antiinflammatory drugs as a possible cause for reversible infertility. Rheumatology (Oxford) 2000; 39:880-882.
67. Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of nonsteroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001; 322:266-270.
68. Li D, Liu L, Odouli R. Exposure to nonsteroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003; 327:1-5.
69. Nakhai-pour HR, Broy P, Sheehy O, Bérard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs. Can Med Assoc J 2011; 183:1713-1720.
70. Edelman AB, Jensen JT, Doom C, Hennebold JD. Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women. Contraception 2013; 87:352-357.
71. Bata MS, Al-Ramahi M, Salhab AS, et al. Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study. J Clin Pharmacol 2006; 46:925-932.
72. Brouwer J, Hazes JM, Laven JS, Dolhain RJ. High disease activity and preconceptual use of prednisone and nonsteroidal anti-inflammatory drugs impair fertiltiy in women with rheumatoid arthritis. Ann Rheum Dis 2013; 72:419.
73. Gromnica-Ihle E, Krüger K. Use of methotrexate in young patients with respect to the reproductive system. Clin Exp Rheumatol 2010; 28:S80-S84.
74. Boots CE, Gustofson RL, Feinberg EC. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness? Fertil Steril 2013; 100:1590-1593.
75. Oriol B, Barrio A, Pacheco A, et al. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertil Steril 2008; 90:1579-1582.
76. Lloyd ME, Carr M, McElhatton P, et al. The effects of methotrexate on pregnancy, fertility and lactation. QJM 1999; 92:551-563.
77. Martinez Lopez JA, Loza E, Carmona L. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin Exp Rheumatol 2009; 27:678-684.
78. Karri S, VanithakumariF G. Effect of methotrexate and leucovorin on female reproductive tract of albino rats. Cell Biochem Funct 2011; 29:1-21.